Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product

International Journal of Cancer

Volumn 73, Issue 1, 1997, Pages 125-130

  Visseren, Marjan J W ^a   Van der Burg, Sjoerd H ^a   Van der Voort, Ellen I H ^a   Brandt, Remco M P ^a   Schrier, Peter T ^a   Van der Bruggen, Pierre ^b   Boon, Thierry ^b   Melief, Cornelis J M ^a   Martin Kast, W ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^c LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; CANCER VACCINE; HLA A ANTIGEN; MAGEB2 PROTEIN, HUMAN; MAGEB2 PROTEIN, MOUSE; TUMOR ANTIGEN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; HLA SYSTEM; LARYNX TUMOR; LUNG TUMOR; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN PROCESSING; SARCOMA; TISSUE SPECIFICITY; TRANSGENIC MOUSE; ANIMAL; CELL STRAIN COS1; HUMAN; IMMUNOLOGY; NEOPLASM;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; COS CELLS; EPITOPES; HLA-A ANTIGENS; HUMANS; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030611816     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970926)73:1<125::AID-IJC19>3.0.CO;2-F     Document Type: Article

References (25)

1. BAKKER, A.B.H., SCHREURS, M.W.J., DE BOER, A.J., KAWAKAMI, Y., ROSENBER, S.A., ADEMA, G.J. and FIGDOR, C.G., Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. exp. Med., 179, 1005-1009 (1994).
2. COULIE, P.O., BRICHARD, V., VAN PEL, A., WÖLFEL, T., SCHNEIDER, J., TRAVERSARI, C., MATEI, S., DE PLAEN, E., LURQUIN, C., SZIKORA, J.-P., RENAULD, J.-C. and BOON, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 180, 35-42 (1994).
3. D' AMARO, J., HOUBIERS, J.G.A., DRIJFHOLT, J.-W., BRANDT, R.M.P., SCHIPPER, R., BOUWES BAVINCK, J.N., MELIEF, C.J.M. and KAST, W.M., A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide binding motifs. Hum. Immunol., 43, 13-18 (1995).
4. DE BACKER, O., VERHEYDEN, A.-M., MARTIN, B., GODELAINE, D., DE PLAEN, E., BRASSEUR, R., AVNER, P. and BOON, T., Strucutre, chromosomal location and expression pattern of three mouse genes homologous to the human MAGE genes. Genomics, 28, 74-83 (1995).
5. DE PLAEN, E. and 14 OTHERS, Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics, 40, 360-369(1994).
6. DE, SMET, C., LURQUIN, C., VAN DER BRUGGEN, P., DE PLAEN, E., BRASSEUR. F. and BOON, T., Sequence and expression pattern of expression of human gene MAGE-2. Immunogenetics, 39, 121-129 (1994).
7. FALK, K., RÖTSCHKE, O., STEVANOVIC, S., JUNG, G. and RAMMENSEE, H.G., Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.), 351, 290-296 (1991).
8. FELTKAMP, M.C.W., SMITS, H.L., VIERBOOM, M.P.M., MINNAAR, R.P., DE JONGH, B.M., DRIJFHOUT, J.W., TER SCHEGGET, J., MELIEF, C.J.M. and KAST, W.M., Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Europ. J. Immunol., 23, 2242-2249 (1993).
9. IMANISHI, T., AKAZA, T. and KIMURA, A., Allele and haplotype frequencies tor HLA and complement loci in various ethnic groups. In: Tsuji K., M. Aizowa, and T. Sasazuki (eds.), HLA 1991, Proceedings of the Eleventh International Histocompatibility Workshop and Conference, pp. 1066-1077. Oxford University Press (1992).
10. MELIEF, C.J.M. and KAST, W.M., Lessons from T cell responses to virus-induced tumors for cancer eradication in general. Cancer Surv., 13, 81-99 (1992).
11. MiLLICH, D.R., HUGHES, J.L., MCLACHLAN, A., THORNTON, G.B. and MORIARTY, A., Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope. Proc. nat. Acad. Sci. (Wash.), 85, 1610-1615 (1988).
12. MIZOGUCHI, H., O'SHEA, J.J., LONGO, D.L., LOEFFLER, C.M., MCVICAR. D.W., and OCHOA, A.C., Alteration in signal transduction molecules in T lymphocytes from tumor bearing mice. Science, 158, 1795-1798 (1992).
13. MORRISON, J., ELVIN, J., LATRON, F., GOTCH, F., MOOTS, R., STROMINGER, J.L. and MCMICHAEL., A., Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Europ. J. Immunol., 22, 903-907 (1992).
14. PARDOLL, D.M., A new look for the 1990s. Nature (Lond.), 369, 357-358 (1994).
15. RUITER, D.J., BERGMAN, W., WELVAART, K., SCHEFFER, E., VAN VLOTEN, W.A., RUSSO, C. and FERRONE, S., Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens. Cancer Res., 44, 3930-3935 (1984).
16. THEOBALD, M., BIGGS, J., DITTMER, D., LEVINE, A.J. and SHERMAN, L.A., Targeting p53 as a general tumor antigen. Proc. nat. Acad. Sci. (Wash.), 92, 11993-11997 (1995).
17. TORRE-AMIONE, G., BEAUCHAMP, R.D., KOEPPEN, H., PARK, B.H., SCHREIBER, H., MOSES, H.L. and ROWLEY, D.A., A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc. nat. Acad. Sci. (Wash.), 87, 1486-1490 (1990).
18. TOWNSEND, A.R.M., ROTHBARD, J., GOTCH, F.M., BAHADUR, G., WRAITH, D. and MCMICHAEL, A.J., The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 44, 959-968 (1986).
19. TRAVHRSARI, C., VAN DER BRUGGEN, P., VAN DEN EYNDE, B., HAINALT, P., LEMOINE, C., OHTAK, N., OLD, L. and BOON, T., Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous CTL. Immunogenetics, 35, 145-152 (1992).
20. VAN DER BRUKIEN, P., BASTIN, J., GAJEWSKI, T., COULIE, P.G., BOËL, P., DE SMET, C., TRAVERSARI, C., TOWNSEND, A. and BOON, T., A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Europ. J. Immunol., 24, 3038-3043 (1994).
21. VAN DER BURG, S.H., VISSEREN, M.J.W., BRANDT, R.M.P., KAST, W.M. and MELIEF, C.J.M., Immunogenicity of peptides bound 10 MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol., 156, 3308-3314 (1996).
22. VISSEREN, M.J.W., KOOT, M., VAN DER VOORT, E.I.H., GRAVESTEIN, L.A., SCHOENMAKERS, H.J,. KAST, W.M., ZIJLSTRA, M. and MELIEF, C.J.M., Production of interleukin-2 by BL4 tumor cells induces natural killer celland T-cell-mediated immunity. J. Immunother., 15, 119-128 (1994).
23. VISSEREN, M.J.W., VAN ELSAS, A., VAN DER VOORT, E.I.H., RESSING, M.E., KAST, W.M., SCHRIER, P.I. and MELIEF, C.J.M., CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J. Immunol., 154, 3991-3998 (1995).
24. VITIELLO, A., MARCHESINI, D., FURZE, J., SHERMAN, L.A. and CHESNUT, R.W., Analysis of the HLA-restricted Influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocomputibilily complex. J. exp. Med., 173, 1007-1015 (1991).
25. WÖLFEL, T., VAN PEL, A., BRICHARD, V., SCHNEIDER, J., SELIGER, B., MEYER ZUM BÜSCHENFELDE, K.H. and BOON, T., Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Europ. J. Imnnmol, 24, 759-764 (1994).